Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up - Takeaways - MDSpire

Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up

  • By

  • Kevin A. Huynh

  • Eva C. Coopmans

  • Amir H. Zamanipoor Najafabadi

  • Linda Dirven

  • Saskia M. Peerdeman

  • Nienke R. Biermasz

  • Marco J. T. Verstegen

  • Wouter R. van Furth

  • January 10, 2023

  • 0 min

Share

  • 1

    Meningiomas are the most common primary intracranial tumors, with 80% classified as benign WHO grade I, allowing for near-normal life expectancy.

  • 2

    Despite total resection, meningioma patients report significant long-term disease burden, including impairments in physical and emotional health.

  • 3

    Patients with meningiomas experience higher rates of anxiety, depression, and neurocognitive deficits compared to healthy controls.

  • 4

    This study aims to assess healthcare utilization and costs among meningioma patients during long-term follow-up to identify determinants of care.

  • 5

    Healthcare costs were calculated based on reported utilization, including medical specialist care, mental healthcare, and medication costs.

Original Source(s)

Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up

  • by Kevin A. Huynh, Eva C. Coopmans, Amir H. Zamanipoor Najafabadi, Linda Dirven, Saskia M. Peerdeman, Nienke R. Biermasz, Marco J. T. Verstegen, Wouter R. van Furth

  • January 10, 2023

Related Content

Evaluating the psychosocial effects of cancer on sleep quality and mental health in elderly populations

The Effects of Anxiety and Depression on Outcomes in Hematologic Malignancies: A Systematic Review and Meta-Analysis

Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial